Factors predictive for response of follicular and mantle-cell lymphoma to rituximab

被引：0
|
作者：
Michael Pfreundschuh
机构：
[1] Professor of Internal Medicine at Saarland University Medical School,
来源：
Nature Clinical Practice Oncology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：184 / 185
页数：1
相关论文
共 50 条
  • [31] Composite mantle-cell lymphoma and classical Hodgkin lymphoma
    Hayes, SJ
    Banerjee, SS
    Cook, Y
    Houghton, JB
    Menasce, LP
    HISTOPATHOLOGY, 2006, 48 (05) : 621 - 623
  • [32] Limited-stage mantle-cell lymphoma
    Leitch, HA
    Gascoyne, RD
    Chhanabhai, M
    Voss, NJ
    Klasa, R
    Connors, JM
    ANNALS OF ONCOLOGY, 2003, 14 (10) : 1555 - 1561
  • [33] Treatment of Older Patients with Mantle-Cell Lymphoma
    Takahashi, Yukie
    Mori, Jinichi
    Tanimoto, Tetsuya
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18): : 1765 - 1765
  • [34] Mantle-cell lymphoma: Classification and therapeutic implications
    Fisher, RI
    ANNALS OF ONCOLOGY, 1996, 7 : 35 - 39
  • [35] Current treatment approaches for mantle-cell lymphoma
    Witzig, TE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) : 6409 - 6414
  • [36] Rituximab Plus Gemcitabine and Oxaliplatin As Salvage Therapy in Patients with Relapsed/Refractory Mantle-Cell Lymphoma
    Gironella, Mercedes
    Lopez, Andres
    Merchan, Brayan
    Abrisqueta, Pau
    Jaramillo, Anny
    Bosch, Francesc
    BLOOD, 2012, 120 (21)
  • [37] Treatment of Older Patients with Mantle-Cell Lymphoma
    Kluin-Nelemans, H. C.
    Hoster, E.
    Hermine, O.
    Walewski, J.
    Trneny, M.
    Geisler, C. H.
    Stilgenbauer, S.
    Thieblemont, C.
    Vehling-Kaiser, U.
    Doorduijn, J. K.
    Coiffier, B.
    Forstpointner, R.
    Tilly, H.
    Kanz, L.
    Feugier, P.
    Szymczyk, M.
    Hallek, M.
    Kremers, S.
    Lepeu, G.
    Sanhes, L.
    Zijlstra, J. M.
    Bouabdallah, R.
    Lugtenburg, P. J.
    Macro, M.
    Pfreundschuh, M.
    Prochazka, V.
    Di Raimondo, F.
    Ribrag, V.
    Uppenkamp, M.
    Andre, M.
    Klapper, W.
    Hiddemann, W.
    Unterhalt, M.
    Dreyling, M. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (06): : 520 - 531
  • [38] Bortezomib treatment for patients with mantle-cell lymphoma
    Tanday, Sanjay
    LANCET ONCOLOGY, 2015, 16 (04): : E162 - E162
  • [39] Duodenal polyyposis disclosing mantle-cell lymphoma
    Moulin, O
    Boucher, E
    Samson, T
    Coutant, G
    Helie, C
    Algayres, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (11): : 1055 - 1057
  • [40] A BTK INHIBITOR IS EFFECTIVE IN MANTLE-CELL LYMPHOMA
    不详
    CANCER DISCOVERY, 2013, 3 (08) : 839 - 839
12345